March 7, 2022
Researchers at the University of Cincinnati are expanding the Genetics of Unusual and Familial Movement Disorders study to include genetic testing for Chilean patients in search of a diagnosis for patients with rare movement disorders.
August 10, 2022
Medium featured the research of the University of Cincinnati's Jiajie Diao, PhD, who recently published a paper showing early results that light-activated proteins can help normalize dysfunction within cells.
September 29, 2022
Laser Focus World's Photonics Hot List highlighted the recent work of the University of Cincinnati's Jiajie Diao, PhD, who published research demonstrating a technique that uses light to help naturally balance mitochondria within cells.
September 6, 2022
University of Cincinnati and Cincinnati Children's Hospital Medical Center researchers published new findings on metabolic signatures that help predict breast cancer outcomes and could open avenues for new treatments in the journal PLOS ONE.
January 2, 2019
When Michael Kattoura studied at the University of Cincinnati, he not only earned his PhD but also helped pass the torch to new researchers, building leadership skills along the way. As a student in UC's College of Engineering and Applied Science between 2013 and 2017, he worked as a teaching assistant for the Department of Mechanical and Materials Engineering and also as a research assistant at the Ohio Center for Laser Shock Processing for Advanced Materials and Devices lab. In January 2015, he became the most senior PhD student at the LSP lab and thus took the responsibility of laboratory equipment training and management.
October 6, 2022
The University of Cincinnati Brain Tumor Center (BTC) held its second-annual Clinical Research Retreat on Sept. 30, bringing researchers from around the country together to discuss advancements in neuro-oncology clinical research.
September 28, 2022
The University of Cincinnati's Alberto Espay, MD, was featured in an NBC News article reporting on results from a phase three Alzheimer's drug trial.